Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1330297rdf:typepubmed:Citationlld:pubmed
pubmed-article:1330297lifeskim:mentionsumls-concept:C0330390lld:lifeskim
pubmed-article:1330297lifeskim:mentionsumls-concept:C0023467lld:lifeskim
pubmed-article:1330297lifeskim:mentionsumls-concept:C0205147lld:lifeskim
pubmed-article:1330297lifeskim:mentionsumls-concept:C0017287lld:lifeskim
pubmed-article:1330297lifeskim:mentionsumls-concept:C0002085lld:lifeskim
pubmed-article:1330297lifeskim:mentionsumls-concept:C0524891lld:lifeskim
pubmed-article:1330297lifeskim:mentionsumls-concept:C1549781lld:lifeskim
pubmed-article:1330297lifeskim:mentionsumls-concept:C1709305lld:lifeskim
pubmed-article:1330297pubmed:issue23lld:pubmed
pubmed-article:1330297pubmed:dateCreated1992-12-16lld:pubmed
pubmed-article:1330297pubmed:abstractTextThe epigenetic phenomenon could play a role in the interaction between chromatin and DNA-binding enzymes, allowing us to consider an association between the phenomenon and gene rearrangement. The correlation between methylation status and rearrangement of the T-cell receptor (TCR) beta chain gene in leukemia cells obtained from patients with acute myeloid leukemia (AML) was examined. All of the AML patients with a TCR-beta rearrangement had hypomethylated CCGG sequences within the J beta 1 region on the rearranged allele, while the germline allele had completely methylated CCmeGG sequence in this region, indicating a strong association between hypomethylation status and rearrangement of the TCR beta chain gene. In the DNA from AML patients with or without a TCR-beta rearrangement, the C beta 2 region contained completely methylated CCmeGG sequences, even though they express T-cell-associated antigens, including CD7; this pattern is quite different from that observed in T-cell neoplasias. Moreover, some AML patients showed a TCR-beta rearrangement without the presence of immunoglobulin heavy-chain gene rearrangement, suggesting that TCR beta chain gene involvement in AML is required for unknown factors other than common recombinase activity.lld:pubmed
pubmed-article:1330297pubmed:languageenglld:pubmed
pubmed-article:1330297pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1330297pubmed:citationSubsetIMlld:pubmed
pubmed-article:1330297pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1330297pubmed:statusMEDLINElld:pubmed
pubmed-article:1330297pubmed:monthDeclld:pubmed
pubmed-article:1330297pubmed:issn0008-5472lld:pubmed
pubmed-article:1330297pubmed:authorpubmed-author:NakazawaSSlld:pubmed
pubmed-article:1330297pubmed:authorpubmed-author:ToyamaKKlld:pubmed
pubmed-article:1330297pubmed:authorpubmed-author:KimuraNNlld:pubmed
pubmed-article:1330297pubmed:authorpubmed-author:KawakuboKKlld:pubmed
pubmed-article:1330297pubmed:authorpubmed-author:OhyashikiKKlld:pubmed
pubmed-article:1330297pubmed:authorpubmed-author:TauchiTTlld:pubmed
pubmed-article:1330297pubmed:authorpubmed-author:OhyashikiJ...lld:pubmed
pubmed-article:1330297pubmed:issnTypePrintlld:pubmed
pubmed-article:1330297pubmed:day1lld:pubmed
pubmed-article:1330297pubmed:volume52lld:pubmed
pubmed-article:1330297pubmed:ownerNLMlld:pubmed
pubmed-article:1330297pubmed:authorsCompleteYlld:pubmed
pubmed-article:1330297pubmed:pagination6598-602lld:pubmed
pubmed-article:1330297pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:1330297pubmed:meshHeadingpubmed-meshheading:1330297-...lld:pubmed
pubmed-article:1330297pubmed:meshHeadingpubmed-meshheading:1330297-...lld:pubmed
pubmed-article:1330297pubmed:meshHeadingpubmed-meshheading:1330297-...lld:pubmed
pubmed-article:1330297pubmed:meshHeadingpubmed-meshheading:1330297-...lld:pubmed
pubmed-article:1330297pubmed:meshHeadingpubmed-meshheading:1330297-...lld:pubmed
pubmed-article:1330297pubmed:meshHeadingpubmed-meshheading:1330297-...lld:pubmed
pubmed-article:1330297pubmed:meshHeadingpubmed-meshheading:1330297-...lld:pubmed
pubmed-article:1330297pubmed:meshHeadingpubmed-meshheading:1330297-...lld:pubmed
pubmed-article:1330297pubmed:meshHeadingpubmed-meshheading:1330297-...lld:pubmed
pubmed-article:1330297pubmed:meshHeadingpubmed-meshheading:1330297-...lld:pubmed
pubmed-article:1330297pubmed:meshHeadingpubmed-meshheading:1330297-...lld:pubmed
pubmed-article:1330297pubmed:meshHeadingpubmed-meshheading:1330297-...lld:pubmed
pubmed-article:1330297pubmed:meshHeadingpubmed-meshheading:1330297-...lld:pubmed
pubmed-article:1330297pubmed:meshHeadingpubmed-meshheading:1330297-...lld:pubmed
pubmed-article:1330297pubmed:meshHeadingpubmed-meshheading:1330297-...lld:pubmed
pubmed-article:1330297pubmed:year1992lld:pubmed
pubmed-article:1330297pubmed:articleTitleT-cell receptor beta chain gene rearrangement in acute myeloid leukemia always occurs at the allele that contains the undermethylated J beta 1 region.lld:pubmed
pubmed-article:1330297pubmed:affiliationFirst Department of Internal Medicine, Tokyo Medical College, Japan.lld:pubmed
pubmed-article:1330297pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1330297pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1330297lld:pubmed